Finance Friday: 11 February 2011

By Alan, on February 11th, 2011

(Photos8.com)

Here are recent financial transactions for science- and engineering-based companies reported by Xconomy.

Biomedical/Life Sciences

AcelRx Pharmaceuticals in Redwood City, California. Pain medications. $40 million IPO: 8 million shares @ $5.00.

Optimer Pharmaceuticals in San Diego, California. Antibiotics. $67.5 million stock offering: 6 million shares @ $11.25.

Fluidigm in South San Francisco, California. $75.6 million IPO: 5.6 million shares @ $13.50.

Arsanis in Lebanon, New Hampshire. Biotechnology. $9.6 million, equity.

Marina Biotech in Bothell, Washington. Cancer drugs. $5.1 million, equity.

Dendreon in Seattle, Washington. Cancer drugs. $80 million, debt.

Oncothyreon in Seattle, Washington. Cancer drugs. $12.5 million, debt.

Seattle Genetics in Bothell, Washington. Cancer drugs. $23.25 million stock offering: 1.5 million shares @ $15.50.

Ecochlor in Acton, Massachusetts. Industrial anti-pathogen systems. $1.7 million, equity.

Physical Sciences

Shocking Technologies in San Jose, California, Polymer dielectric materials. $5.2 million, equity.

Engineering and Electronics

Tela Innovations in Los Gatos, California. Semiconductor fabrication. $4.75 million, equity.

* * *